[HTML][HTML] Acinetobacter Non-baumannii Species: Occurrence in Infections in Hospitalized Patients, Identification, and Antibiotic Resistance

E Sheck, A Romanov, V Shapovalova, E Shaidullina… - Antibiotics, 2023 - mdpi.com
Background: Acinetobacter species other than A. baumannii are becoming increasingly
more important as opportunistic pathogens for humans. The primary aim of this study was to …

Complete genome sequencing of Acinetobacter baumannii AC1633 and Acinetobacter nosocomialis AC1530 unveils a large multidrug-resistant plasmid encoding the …

AG Alattraqchi, F Mohd Rani, NI A. Rahman, S Ismail… - MSphere, 2021 - Am Soc Microbiol
Carbapenem-resistant Acinetobacter spp. are considered priority drug-resistant human-
pathogenic bacteria. The genomes of two carbapenem-resistant Acinetobacter spp. clinical …

Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia

MHN A'shimi, AG Alattraqchi, FM Rani… - The Journal of Infection …, 2019 - jidc.org
Introduction. Acinetobacter baumannii is a Gram-negative nosocomial pathogen that has the
capacity to develop resistance to all classes of antimicrobial compounds. However, very little …

Epidemiology and Multidrug Resistance of Pseudomonas aeruginosa and Acinetobacter baumanni Isolated from Clinical Samples in Ethiopia

S Araya, Z Gebreyohannes, G Tadlo… - Infection and Drug …, 2023 - Taylor & Francis
Background A. baumannii and P. aeruginosa are important nosocomial pathogens in health-
care settings. Both are intrinsically resistant to many drugs and are able to become resistant …

[HTML][HTML] TonB-Dependent Receptor Protein Displayed on Spores of Bacillus subtilis Stimulates Protective Immune Responses against Acinetobacter baumannii

NA MatRahim, KM Jones, BP Keegan, U Strych… - Vaccines, 2023 - mdpi.com
The emergence of antibiotic-resistant Acinetobacter baumannii strains with limited treatment
options has become a significant global health concern. Efforts to develop vaccines against …

[HTML][HTML] Comparative genomic analysis of clinical Acinetobacter nosocomialis isolates from Terengganu, Malaysia led to the discovery of a novel tetracycline-resistant …

FM Rani, SS Lean, NIA Rahman, S Ismail… - Journal of Global …, 2022 - Elsevier
Objectives To analyse the genome sequences of four archival Acinetobacter nosocomialis
clinical isolates (designated AC13, AC15, AC21 and AC25) obtained from Terengganu …

Prevalence and antimicrobial resistance pattern of Acinetobacter baumannii isolates from intensive care units in Zagazig University Hospitals

WE Lotfy, RH Anis - Microbes and Infectious Diseases, 2021 - journals.ekb.eg
Background: Multidrug resistant (MDR) Acinetobacter baumannii (A. baumannii) has been
recognized as a serious causative agent of health care associated infections (HAIs) in …

Detection of Genes of Efflux Pumps (adeB, adeJ and adeG) in Tigecycline Resistant Acinetobacter baumannii Isolated from Benha University Hospital

ALSM ALTabbakh, SA Saied, A Shahat - Egyptian Journal of …, 2022 - journals.ekb.eg
Background: Emerging of tigecycline resistant Acinetobacter baumannii (A. baumannii) is a
critical global health problem as tigecycline is considered the last-line antibiotic for treatment …

[PDF][PDF] Complete genome sequencing of Acinetobacter baumannii AC1633 and Acinetobacter nosocomialis AC1530 unveils a large multidrug-resistant plasmid …

DW Cleary, SC Clarke, CC Yeo - 2021 - research.birmingham.ac.uk
Carbapenem-resistant Acinetobacter spp. are considered priority drugresistant human-
pathogenic bacteria. The genomes of two carbapenem-resistant Acinetobacter spp. clinical …

[PDF][PDF] Microbes and Infectious Diseases

SS Shaban, A Hadhoud, WE Lotfy, RH Anis - 2020 - scholar.archive.org
ABSTRACT Background: Multidrug resistant (MDR) Acinetobacter baumannii (A. baumannii)
has been recognized as a serious causative agent of health care associated infections …